NEW HAVEN, Conn., June 3, 2010 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that Milind S. Deshpande, Executive Vice President and Chief Scientific Officer, will give a corporate overview and update on the Company’s HCV programs at the at the Noble Financial 6th Annual Equity Conference on June 8, 2010 at 10:00 a.m. at the Hard Rock Hotel in Hollywood, Florida.
